Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/02/23
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 05/10/19
End: 03/01/23
Due: 03/01/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 1 Study of Intratumoral Administration of VAX014 in Subjects with Advanced Solid Tumors | NCT05901285 | Vaxiion Therapeutics | user2@example.com | None | 2023-11-02 | 2026-05-31 | 2027-05-31 | - | - | 2025-07-14 |
| A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer | NCT03854721 | Vaxiion Therapeutics | user2@example.com | None | 2019-05-10 | 2023-03-01 | 2024-03-01 | - | - | 2025-07-14 |